Follow
Yibin Kang
Yibin Kang
Warner-Lambert/Parke-Davis Professor of Molecular Biology, Princeton University
Verified email at princeton.edu
Title
Cited by
Cited by
Year
Tumour exosome integrins determine organotropic metastasis
A Hoshino, B Costa-Silva, TL Shen, G Rodrigues, A Hashimoto, ...
Nature 527 (7578), 329-335, 2015
44502015
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
H Peinado, M Alečković, S Lavotshkin, I Matei, B Costa-Silva, ...
Nature medicine 18 (6), 883-891, 2012
38252012
A multigenic program mediating breast cancer metastasis to bone
Y Kang, PM Siegel, W Shu, M Drobnjak, SM Kakonen, C Cordón-Cardo, ...
Cancer cell 3 (6), 537-549, 2003
31472003
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2
M Korpal, ES Lee, G Hu, Y Kang
Journal of Biological Chemistry 283 (22), 14910-14914, 2008
19832008
Epithelial-mesenchymal transitions: twist in development and metastasis
Y Kang, J Massagué
Cell 118 (3), 277-279, 2004
19262004
Pre-metastatic niches: organ-specific homes for metastases
H Peinado, H Zhang, IR Matei, B Costa-Silva, A Hoshino, G Rodrigues, ...
Nature Reviews Cancer 17 (5), 302-317, 2017
15812017
Guidelines and definitions for research on epithelial–mesenchymal transition
J Yang, P Antin, G Berx, C Blanpain, T Brabletz, M Bronner, K Campbell, ...
Nature reviews Molecular cell biology 21 (6), 341-352, 2020
13342020
Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors
AJ Minn, Y Kang, I Serganova, GP Gupta, DD Giri, M Doubrovin, ...
The Journal of clinical investigation 115 (1), 44-55, 2005
9312005
Beyond tumorigenesis: cancer stem cells in metastasis
F Li, B Tiede, J Massagué, Y Kang
Cell research 17 (1), 3-14, 2007
8522007
Tumor metastasis: moving new biological insights into the clinic
L Wan, K Pantel, Y Kang
Nature medicine 19 (11), 1450-1464, 2013
8062013
Hypoxia and hypoxia-inducible factors: master regulators of metastasis
X Lu, Y Kang
Clinical cancer research 16 (24), 5928-5935, 2010
7922010
Extracellular vesicle and particle biomarkers define multiple human cancers
A Hoshino, HS Kim, L Bojmar, KE Gyan, M Cioffi, J Hernandez, ...
Cell 182 (4), 1044-1061. e18, 2020
7872020
A self-enabling TGFβ response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells
Y Kang, CR Chen, J Massagué
Molecular cell 11 (4), 915-926, 2003
7452003
Epithelial-mesenchymal plasticity in cancer progression and metastasis
W Lu, Y Kang
Developmental cell 49 (3), 361-374, 2019
7362019
Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization
M Korpal, BJ Ell, FM Buffa, T Ibrahim, MA Blanco, T Celià-Terrassa, ...
Nature medicine 17 (9), 1101-1108, 2011
7082011
Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells
N Sethi, X Dai, CG Winter, Y Kang
Cancer cell 19 (2), 192-205, 2011
6642011
E2F4/5 and p107 as Smad cofactors linking the TGFβ receptor to c-myc repression
CR Chen, Y Kang, PM Siegel, J Massagué
Cell 110 (1), 19-32, 2002
6622002
Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway
Y Kang, W He, S Tulley, GP Gupta, I Serganova, CR Chen, ...
Proceedings of the National Academy of Sciences 102 (39), 13909-13914, 2005
6352005
VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors
X Lu, E Mu, Y Wei, S Riethdorf, Q Yang, M Yuan, J Yan, Y Hua, BJ Tiede, ...
Cancer cell 20 (6), 701-714, 2011
5492011
MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer
G Hu, RA Chong, Q Yang, Y Wei, MA Blanco, F Li, M Reiss, JLS Au, ...
Cancer cell 15 (1), 9-20, 2009
5092009
The system can't perform the operation now. Try again later.
Articles 1–20